Stay updated on Cabozantinib in Solid Tumors & HIV Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.

Latest updates to the Cabozantinib in Solid Tumors & HIV Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.4.3; Removed Revision: v3.4.2.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to trial content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedThe website shows a revision update from v3.4.0 to v3.4.1, with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThese are minor UI/metadata updates: a glossary toggle was added, the QC date label was updated to 'Last Update Submitted that Met QC Criteria', and the page version noted as 'Revision: v3.4.0' while older wording and the prior version label were removed.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib in Solid Tumors & HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.